| Nov 15 |
RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
|
| Nov 14 |
Compass Pathways to participate in Stifel 2024 Healthcare Conference
|
| Nov 6 |
Massachusetts psychedelics legalization initiative poised to fail
|
| Nov 5 |
Top 3 Health Care Stocks You'll Regret Missing In November
|
| Nov 4 |
Compass Pathways: Phase 3 Trial Delay - Both Understandable And Disappointing
|
| Nov 4 |
Compass Pathways: No Near-Term Fix For Struggling Psychedelic Therapy Pioneer
|
| Nov 2 |
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
|
| Nov 1 |
Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
|
| Nov 1 |
Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
|
| Nov 1 |
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
|
